Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11847940rdf:typepubmed:Citationlld:pubmed
pubmed-article:11847940lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:11847940lifeskim:mentionsumls-concept:C1251704lld:lifeskim
pubmed-article:11847940lifeskim:mentionsumls-concept:C0231449lld:lifeskim
pubmed-article:11847940pubmed:issue2lld:pubmed
pubmed-article:11847940pubmed:dateCreated2002-2-18lld:pubmed
pubmed-article:11847940pubmed:abstractTextTo assess the pharmacokinetics, safety, and tolerability of lidocaine delivered via 4 lidocaine 5% patches applied for 18 h/d for 3 consecutive days in healthy volunteers.lld:pubmed
pubmed-article:11847940pubmed:languageenglld:pubmed
pubmed-article:11847940pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11847940pubmed:citationSubsetIMlld:pubmed
pubmed-article:11847940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11847940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11847940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11847940pubmed:statusMEDLINElld:pubmed
pubmed-article:11847940pubmed:monthFeblld:pubmed
pubmed-article:11847940pubmed:issn1060-0280lld:pubmed
pubmed-article:11847940pubmed:authorpubmed-author:GammaitoniArn...lld:pubmed
pubmed-article:11847940pubmed:authorpubmed-author:DavisMatthew...lld:pubmed
pubmed-article:11847940pubmed:issnTypePrintlld:pubmed
pubmed-article:11847940pubmed:volume36lld:pubmed
pubmed-article:11847940pubmed:ownerNLMlld:pubmed
pubmed-article:11847940pubmed:authorsCompleteYlld:pubmed
pubmed-article:11847940pubmed:pagination236-40lld:pubmed
pubmed-article:11847940pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:meshHeadingpubmed-meshheading:11847940...lld:pubmed
pubmed-article:11847940pubmed:year2002lld:pubmed
pubmed-article:11847940pubmed:articleTitlePharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.lld:pubmed
pubmed-article:11847940pubmed:affiliationEndo Pharmaceuticals, 100 Painters Dr., Chadds Ford, PA 19317-9007, USA. gammaitoni.arnold@endo.comlld:pubmed
pubmed-article:11847940pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11847940pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11847940pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11847940lld:pubmed